Targeting Helicobacter pylori in liver-impaired populations: a systematic review of efficacy and safety

Keyphrases

• Liver 100%
• Helicobacter Pylori (H. pylori) 100%
• Helicobacter Pylori Eradication 100%
• Liver Impairment 100%
• Eradication Rate 60%
• Randomized Controlled Trial 40%
• Liver Disease 40%
• Eradication Therapy 40%
• Metabolic Flexibility 40%
• Non-randomized Controlled Trial 40%
• No Significant Difference 20%
• Adverse Events 20%
• PubMed 20%
• Liver Cirrhosis 20%
• Liver Dysfunction 20%
• Nonalcoholic Steatohepatitis 20%
• Standardized Guidelines 20%
• Cochrane Library 20%
• Library Databases 20%
• Disease Groups 20%
• Patients with Liver Disease 20%
• Treatment Indication 20%
• Potential Adverse Effects 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Helicobacter Pylori 100%
• Randomized Controlled Trial 66%
• Liver Disease 50%
• Adverse Event 33%
• Nonalcoholic Fatty Liver 16%
• Liver Cirrhosis 16%
• Liver Dysfunction 16%